BIOL
Income statement / Annual
Last year (2023), BIOLASE, Inc.'s total revenue was $49.16 M,
an increase of 1.45% from the previous year.
In 2023, BIOLASE, Inc.'s net income was -$20.63 M.
See BIOLASE, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$49.16 M
|
$48.46 M
|
$39.19 M
|
$22.78 M
|
$37.80 M
|
$46.16 M
|
$46.93 M
|
$51.81 M
|
$48.48 M
|
$47.66 M
|
| Cost of Revenue |
$32.44 M |
$32.55 M |
$22.66 M |
$16.61 M |
$23.51 M |
$29.26 M |
$31.80 M |
$31.50 M |
$32.53 M |
$29.48 M |
| Gross Profit |
$16.72 M |
$15.91 M |
$16.53 M |
$6.17 M |
$14.29 M |
$16.90 M |
$15.13 M |
$20.31 M |
$15.95 M |
$18.17 M |
| Gross Profit Ratio |
0.34 |
0.33 |
0.42 |
0.27 |
0.38 |
0.37 |
0.32 |
0.39 |
0.33 |
0.38 |
| Research and Development
Expenses |
$6.00 M
|
$7.27 M
|
$6.05 M
|
$3.70 M
|
$4.77 M
|
$5.20 M
|
$6.23 M
|
$7.80 M
|
$7.28 M
|
$4.58 M
|
| General & Administrative
Expenses |
$10.22 M
|
$12.31 M
|
$11.26 M
|
$9.77 M
|
$10.75 M
|
$11.77 M
|
$9.71 M
|
$10.45 M
|
$10.26 M
|
$14.85 M
|
| Selling & Marketing
Expenses |
$18.44 M
|
$21.68 M
|
$15.34 M
|
$11.24 M
|
$14.40 M
|
$18.12 M
|
$16.72 M
|
$17.02 M
|
$18.70 M
|
$16.38 M
|
| Selling, General &
Administrative Expenses |
$28.66 M
|
$33.98 M
|
$26.60 M
|
$21.01 M
|
$25.14 M
|
$29.89 M
|
$26.43 M
|
$27.47 M
|
$28.95 M
|
$31.23 M
|
| Other Expenses |
$48,000.00 |
$0.00 |
$0.00 |
$4.22 M |
$0.00 |
$0.00 |
$0.00 |
-$348,000.00 |
$361,000.00 |
$307,000.00 |
| Operating Expenses |
$34.66 M |
$41.25 M |
$32.65 M |
$24.71 M |
$29.91 M |
$35.10 M |
$32.66 M |
$35.27 M |
$36.60 M |
$36.11 M |
| Cost And Expenses |
$67.10 M |
$73.80 M |
$55.30 M |
$41.32 M |
$53.42 M |
$64.36 M |
$64.46 M |
$66.77 M |
$69.12 M |
$65.60 M |
| Interest Income |
$0.00 |
$2.75 M |
$2.22 M |
$2.36 M |
$2.16 M |
$0.00 |
$42,000.00 |
$74,000.00 |
$74,000.00 |
$0.00 |
| Interest Expense |
$2.36 M |
$2.75 M |
$2.22 M |
$2.36 M |
$2.16 M |
$510,000.00 |
$0.00 |
$258,000.00 |
$0.00 |
$458,000.00 |
| Depreciation &
Amortization |
$2.80 M
|
$497,000.00
|
$400,000.00
|
$499,000.00
|
$982,000.00
|
$945,000.00
|
$1.20 M
|
$1.05 M
|
$880,000.00
|
$696,000.00
|
| EBITDA |
-$15.14 M
|
-$24.84 M
|
-$15.72 M
|
-$13.84 M
|
-$14.64 M
|
-$17.26 M
|
-$16.33 M
|
-$13.91 M
|
-$19.77 M
|
-$17.25 M
|
| EBITDA Ratio |
-0.31 |
-0.51 |
-0.4 |
-0.61 |
-0.39 |
-0.37 |
-0.35 |
-0.26 |
-0.44 |
-0.38 |
| Operating Income Ratio
|
-0.36
|
-0.52
|
-0.41
|
-0.81
|
-0.41
|
-0.45
|
-0.38
|
-0.29
|
-0.41
|
-0.38
|
| Total Other
Income/Expenses Net |
-$2.66 M
|
-$3.19 M
|
$23,000.00
|
$1.84 M
|
-$2.28 M
|
-$568,000.00
|
$605,000.00
|
-$258,000.00
|
-$185,000.00
|
-$873,000.00
|
| Income Before Tax |
-$20.60 M |
-$28.53 M |
-$16.09 M |
-$16.70 M |
-$17.90 M |
-$21.45 M |
-$17.43 M |
-$15.22 M |
-$20.10 M |
-$18.81 M |
| Income Before Tax Ratio
|
-0.42
|
-0.59
|
-0.41
|
-0.73
|
-0.47
|
-0.46
|
-0.37
|
-0.29
|
-0.41
|
-0.39
|
| Income Tax Expense |
$31,000.00 |
$109,000.00 |
$65,000.00 |
$128,000.00 |
-$44,000.00 |
$63,000.00 |
-$582,000.00 |
$151,000.00 |
$178,000.00 |
$112,000.00 |
| Net Income |
-$20.63 M |
-$28.63 M |
-$16.16 M |
-$16.83 M |
-$17.86 M |
-$21.52 M |
-$16.85 M |
-$15.37 M |
-$20.28 M |
-$18.93 M |
| Net Income Ratio |
-0.42 |
-0.59 |
-0.41 |
-0.74 |
-0.47 |
-0.47 |
-0.36 |
-0.3 |
-0.42 |
-0.4 |
| EPS |
-16.14 |
-413.19 |
-273.41 |
-688.19 |
-1923.95 |
-2612.75 |
-2856.1 |
-3167.32 |
-4356.18 |
-5258.68 |
| EPS Diluted |
-16.14 |
-413.19 |
-273.41 |
-688.19 |
-1923.95 |
-2612.75 |
-2856.1 |
-3167.32 |
-4356.18 |
-5258.68 |
| Weighted Average Shares
Out |
$1.28 M
|
$69,300.00
|
$59,098.00
|
$24,454.00
|
$9,280.40
|
$8,235.00
|
$5,900.00
|
$4,853.00
|
$4,655.00
|
$3,599.00
|
| Weighted Average Shares
Out Diluted |
$1.28 M
|
$69,300.00
|
$59,098.00
|
$24,454.00
|
$9,280.40
|
$8,235.00
|
$5,900.00
|
$4,853.00
|
$4,655.00
|
$3,599.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
